Page last updated: 2024-09-23

cinitapride

Cross-References

ID SourceID
PubMed CID68867
CHEMBL ID2104523
CHEBI ID135642
SCHEMBL ID476454
SCHEMBL ID19235643
MeSH IDM0131853

Synonyms (37)

Synonym
cidine
cinitapride hydrogen tartrate
paxapride (tn)
cinitapride (inn)
66564-14-5
D07700
cinitapride
CHEBI:135642
4-amino-n-(1-(3-cyclohexen-1-ylmethyl)-4-piperidyl)-2-ethoxy-5-nitrobenzamide
4-amino-n-[1-(cyclohex-3-en-1-ylmethyl)piperidin-4-yl]-2-ethoxy-5-nitrobenzamide
FT-0665049
BCP9000531
paxapride
CHEMBL2104523
unii-r8i97i2l24
cinitaprida [inn-spanish]
cinitapridum
cinitaprida
r8i97i2l24 ,
cinitapride [inn]
cinitapridum [inn-latin]
BCP0726000107
AKOS015909742
DB08810
SCHEMBL476454
cidin
SCHEMBL19235643
BCP04096
Q5121012
66564-14-5 (free base)
DTXSID60867232
cinitapride [mi]
cinitapride [who-dd]
cinitapride [mart.]
CS-0017505
HY-B2089
AKOS040744830

Research Excerpts

Overview

ExcerptReference
"Cinitapride (CIN) is a benzamide-derived molecule used for the treatment of gastroesophageal reflux and dyspepsia. "( Ángeles, AP; Ávila, Ó; Batista, D; Contreras, L; Esquivel, J; García-González, A; Marcelín-Jiménez, G, 2017)

Effects

ExcerptReference
"Cinitapride has been widely given in gastro-esophageal reflux disease (GERD) and dysphagia due to irregularities of GI motilities. "( Ahmed, K; Ali, H; Bushra, R; Ghayas, S; Shafiq, Y; Zafar, F, 2019)

Actions

ExcerptReference
"Cinitapride had lower risk of total adverse events than domperidone."( Li, Y; Liu, H; Qi, Q; Wang, N, 2023)

Drug Classes (2)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (7.69)18.7374
1990's5 (19.23)18.2507
2000's4 (15.38)29.6817
2010's14 (53.85)24.3611
2020's1 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials11 (37.93%)5.53%
Reviews2 (6.90%)6.00%
Case Studies5 (17.24%)4.05%
Observational0 (0.00%)0.25%
Other11 (37.93%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized, Double-blind, Double-dummy, Active Drug Parallel Controlled, Multi-center Clinical Trial on the Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia[NCT01355276]Phase 3400 participants (Actual)Interventional2010-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Research Highlights

Safety/Toxicity (2)

ArticleYear
Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia.
Journal of clinical gastroenterology, Volume: 48, Issue: 4
2014
Efficacy and safety of cinitapride in functional dyspepsia.
JPMA. The Journal of the Pakistan Medical Association, Volume: 63, Issue: 6
2013
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Long-term Use (1)

ArticleYear
Multiple opiate receptors of brain and spinal cord in opiate addiction.
General pharmacology, Volume: 22, Issue: 5
1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (2)

ArticleYear
Development of an UPLC-MS/MS micromethod for quantitation of cinitapride in plasma and its application in a pharmacokinetic interaction trial.
Bioanalysis, Volume: 9, Issue: 6
2017
The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 35, Issue: 7
2007
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (2)

ArticleYear
Effects of superdisintegrants in oral dissolving formulation of cinitapride tablets.
Pakistan journal of pharmaceutical sciences, Volume: 31, Issue: 2(Suppl.)
2018
Development of an UPLC-MS/MS micromethod for quantitation of cinitapride in plasma and its application in a pharmacokinetic interaction trial.
Bioanalysis, Volume: 9, Issue: 6
2017
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (1)

ArticleYear
Development and validation of stability indicating assay method for cinitapride in bulk & tablets.
Pakistan journal of pharmaceutical sciences, Volume: 30, Issue: 6(Suppleme
2017
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]